miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs

Laura Lupini1, Cristian Bassi, Manuela Ferracin

  • 1Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università di Ferrara Ferrara, Italy.

Insights

MicroRNA miR-221, often elevated in cancers, targets 602 genes involved in cell proliferation and apoptosis. This study identifies new targets, enhancing understanding of miR-221

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNA miR-221 is frequently over-expressed in various human neoplasms.
  • Understanding miR-221's molecular mechanisms in tumorigenesis is crucial.

Purpose of the Study:

  • To identify novel gene targets of miR-221.
  • To elucidate the role of miR-221 in cancer promotion.

Main Methods:

  • Gene expression profiling of miR-221-transfected SNU-398 cells using the Sylamer algorithm.
  • Analysis of down-regulated mRNAs with sequences homologous to miR-221 in their 3'UTRs.
  • Experimental validation of selected miR-221 target genes in multiple cell lines (SNU-398, HepG2, HEK293).

Main Results:

  • Enforced miR-221 expression led to the down-regulation of 602 mRNAs.
  • Pathway analysis indicated significant involvement of these targets in cell proliferation and apoptosis.
  • Activation of key oncogenic pathways (E2F, MYC, NFkB, β-catenin) was confirmed.
  • Validation of specific targets including RB1, WEE1, APAF1, ANXA1, and CTCF.

Conclusions:

  • This study identifies a comprehensive set of miR-221 gene targets.
  • The findings deepen the understanding of miR-221's molecular mechanisms in tumorigenesis.
  • miR-221 promotes cancer by modulating numerous oncogenic pathways through mRNA level changes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...